← Back to Search

Computerized Cognitive Tests for Early Detection of Alzheimer’s Disease

N/A
Recruiting
Research Sponsored by Neurobehavioral Systems, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Must speak Spanish as a primary language (for Latino participants completing our Spanish translation)
Must be able to use computer mouse and touch screen.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up longitudinal testing at six-month intervals
Awards & highlights

Study Summary

This trial will help develop computerized tests to detect early signs of cognitive decline in healthy people of different ages.

Who is the study for?
This trial is for healthy individuals who can use a computer mouse and touchscreen, and speak English or Spanish as their primary language. It's not suitable for those with psychiatric disorders, stroke history, substance abuse, medical conditions affecting testing, traumatic brain injury with hospitalization and extended unconsciousness, epilepsy, depression or anxiety.Check my eligibility
What is being tested?
The study involves performing tasks on a computer to collect standard data for new cognitive tests. These tests aim to identify early signs of age-related cognitive decline potentially leading to Alzheimer's disease in people before symptoms appear.See study design
What are the potential side effects?
Since the intervention involves only computerized cognitive assessments without any drugs or invasive procedures involved, there are no direct physical side effects expected from participating in this trial.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
Spanish is my primary language.
Select...
I can use a computer mouse and touch screen.
Select...
I can use a computer mouse and touch screen.
Select...
English is my primary language.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~longitudinal testing at six-month intervals
This trial's timeline: 3 weeks for screening, Varies for treatment, and longitudinal testing at six-month intervals for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Longitudinal normative data collection from healthy participants

Trial Design

4Treatment groups
Experimental Treatment
Group I: Test-Retest Reliability groupExperimental Treatment1 Intervention
We will gather normative data from participants across the age range (N = 100, ages 18 to 89) for three days at enrollment, to better characterize test-retest reliability scores on Day 1 tasks.
Group II: Older participant groupExperimental Treatment1 Intervention
We will evaluate the performance of healthy older participants (N = 300, age range 60 to 89 years) for three days at enrollment and then at 6-month intervals for three years thereafter. The goal is to characterize changes in performance to aging and task experience in a group of older subjects.
Group III: Health Disparities groupExperimental Treatment1 Intervention
We will evaluate the performance of healthy older participants (N = 1200, age range 50 to 89 years) for three days at enrollment and then at 6-month intervals for three years thereafter. In the aim of better understanding health disparities in cognitive testing, this group will be divided into four cohorts: 300 African American participants; 300 Asian American participants; 300 Latino English-speaking participants; and 300 Latino Spanish-speaking participants, who will complete a Spanish translation of our computerized cognitive tests.
Group IV: CCAB vs. manual test groupExperimental Treatment1 Intervention
We will compare the performance of normal participants (N = 100, age range 18 to 89) on computerized and manually administered cognitive tasks.

Find a Location

Who is running the clinical trial?

Neurobehavioral Systems, Inc.Lead Sponsor
National Institutes of Health (NIH)NIH
2,685 Previous Clinical Trials
6,928,796 Total Patients Enrolled

Media Library

California Cognitive Assessment Battery Clinical Trial Eligibility Overview. Trial Name: NCT04800588 — N/A
Alzheimer's Disease Research Study Groups: Test-Retest Reliability group, Health Disparities group, CCAB vs. manual test group, Older participant group
Alzheimer's Disease Clinical Trial 2023: California Cognitive Assessment Battery Highlights & Side Effects. Trial Name: NCT04800588 — N/A
California Cognitive Assessment Battery 2023 Treatment Timeline for Medical Study. Trial Name: NCT04800588 — N/A
Alzheimer's Disease Patient Testimony for trial: Trial Name: NCT04800588 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this research still accept volunteers?

"According to the clinicaltrials.gov database, this trial is currently in need of participants and was first published on May 1st 2021 with its last edit occurring on March 23rd 2021."

Answered by AI

Is the age cutoff for this trial 85 or younger?

"To be considered for this study, patients must fall between the ages of 18 to 89. Additionally, there are 45 trials available specifically targeting individuals under the legal age and 1141 aimed at those with more advanced years."

Answered by AI

Am I eligible to join this research endeavor?

"2000 people aged between 18 and 89, who are currently living with Alzheimer's disease, will be admitted into this trial. Additionally, the participants must demonstrate their ability to use a computer mouse and touchscreen interface."

Answered by AI

What is the number of participants involved in this trial?

"Affirmative. Clinicaltrials.gov has the details on this clinical trial, which was originally listed in May 2021 and last updated in March of that same year. 2000 participants are needed from one specific medical centre for data collection purposes."

Answered by AI

Who else is applying?

What state do they live in?
California
How old are they?
65+
What site did they apply to?
Neurobehavioral Systems, Inc.
What portion of applicants met pre-screening criteria?
Met criteria
How many prior treatments have patients received?
3+
0

Why did patients apply to this trial?

I would like to help. CuriosityI would like to help. I'm concerned about cognitive decline, since my mother had dementia.
PatientReceived 2+ prior treatments

What questions have other patients asked about this trial?

What is the compensation? I am pre-diabetic. Does that disqualify me?
PatientReceived 1 prior treatment

How responsive is this trial?

Typically responds via
Email
Most responsive sites:
  1. Neurobehavioral Systems, Inc.: < 24 hours
Average response time
  • < 1 Day
Recent research and studies
~1029 spots leftby Mar 2027